Aurelia Bioscience Competitors and Similar CompaniesClear all
Aurelia Bioscience's competitors and similar companies include Pyxant Labs, Interpace Diagnostics, Prometheus Biosciences and Opko Health.
 Aurelia Bioscience Aurelia Bioscience is a pre-clinical contract research organization that delivers biochemical and cell-based compound screening expertise. |  Interpace Diagnostics Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies. |  Prometheus Biosciences Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases. |  Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. | ||
Founding Date | Founding Date 2011 | Founding Date 2000 | Founding Date 1987 | Founding Date 1995 | Founding Date 2007 |
Type | Type Private | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Nottingham, GB HQ | Locations Colorado Springs, US HQ Millcreek, US | Locations Parsippany-Troy Hills, US HQ Morrisville, US Pittsburgh, US | Locations San Diego, US HQ | Locations Miami, US HQ Woburn, US |
Employees | Employees 2 | Employees 1221% decrease | Employees 8919% increase | Employees 9735% increase | Employees 6,0967% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11.5 m | Valuation ($) N/A | Valuation ($) 1.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $38.7m (FY, 2025) | Revenue (est.) $6.8m (FY, 2022) | Revenue (est.) $606.9m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $14.6m (FY, 2025) | Cost of goods N/A | Cost of goods $400.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $24.1m (FY, 2025) | Gross profit N/A | Gross profit $205.9m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income $24.6m (FY, 2025) | Net income ($141.8m) (FY, 2022) | Net income ($225.7m) (FY, 2025) |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) 1 (FY, 2016) | Patents (US) 11 (Mar, 2021) | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 530k | Total funding raised N/A | Total funding raised $ 130m | Total funding raised $ 31m |
For sources of this data, please see the company profile
View Company Profiles
Pyxant Labs
HQ
Colorado Springs, US
Employees
122↓ 1% decrease
Pyxant Labs is a company operating as a bioanalytical laboratory.
View companyInterpace Diagnostics
HQ
Parsippany-Troy Hills, US
Employees
89↑ 19% increase
Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.
View companyPrometheus Biosciences
HQ
San Diego, US
Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.
View companyOpko Health
HQ
Miami, US
Employees
6,096↑ 7% increase
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
View company